The pulmonary collectins and surfactant metabolism

Annual Review of Physiology

Volumn 63, Issue , 2001, Pages 495-519

  Hawgood, S ^a   Poulain, F R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Mouse models; SP A; SP D; Surfactant homeostasis

Indexed keywords

COLLECTIN; LUNG SURFACTANT; MYELIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

GENE LOCUS; HOMEOSTASIS; HUMAN; LIGAND BINDING; LUNG ALVEOLUS; LUNG ALVEOLUS SURFACE TENSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN STRUCTURE; RECEPTOR BINDING; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; REVIEW;

ANIMALS; CARRIER PROTEINS; COLLECTINS; HOMEOSTASIS; MICE; PULMONARY ALVEOLI; PULMONARY SURFACTANTS;

EID: 0035051057     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.63.1.495     Document Type: Review

References (162)

1. Collectins - Soluble proteins containing collagenous regions and lectin domains - And their roles in innate immunity
2. Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR- and CR1-mediated phagocytosis
3. Exon structure of a mannose-binding protein gene reflects its evolutionary relationship to the asialoglycoprotein receptor and nonfibrillar collagens
4. Anti-antibody immunity
5. Immunomodulatory functions of surfactant
6. Surfactant proteins A and D and pulmonary host defense
7. Collectins and pulmonary innate immunity
8. The cDNA cloning of conglutinin and identification of liver as a primary site of synthesis of conglutinin in members of the Bovidae
9. Purification and characterization of a bovine serum lectin (CL-43) with structural homology to conglutinin and SP-D and carbohydrate specificity similar to mannan-binding protein
10. Molecular cloning of a novel human collectin from liver (CL-L1)
11. Lung surfactant proteins (SP-A and SP-D) in non-adaptive host responses to infection
12. C-Type lectin-like domains in Caenorhabditis elegans: Predictions from the complete genome sequence
13. Isolation and characterization of the human pulmonary surfactant apoprotein gene
14. Genomic organization of the mouse gene for lung surfactant protein D
15. Human surfactant protein D: SP-D contains a C-type lectin carbohydrate recognition domain
16. Characterization of the mouse collectin gene locus
17. Organization of the human SP-A and SP-D loci at 10q22-q23. Physical and radiation hybrid mapping reveal gene order and orientation
18. Mouse surfactant protein-D, cDNA cloning, characterization, and gene localization to chromosome 14
19. Macromolecular organization of natural and recombinant lung surfactant protein SP 28-36. Structural homology with the complement factor C1q
20. Structure, biologic properties, and expression of surfactant protein D (SP-D)
21. A parallel three stranded alpha-helical bundle at the nucleation site of collagen triplehelix formation
22. C-type lectin-like domains
23. Structure of the calcium-dependent lectin domain from a rat mannose-binding protein determined by MAD phasing
24. Trimeric structure of a C-type mannose-binding protein
25. Human mannose-binding protein carbohydrate recognition domain trimerizes through a triple alpha-helical coiled-coil
26. Crystal structure of the trimeric alpha-helical, coiled-coil and the three lectin domains of human lung surfactant protein D
27. Structural basis of lectin-carbohydrate recognition
28. The major lung surfactant protein, SP 28-36, is a calcium-dependent, carbohydrate-binding protein
29. Surfactant protein D is a divalent cation-dependent carbohydrate-binding protein
30. Structure of a C-type mannose-binding protein complexed with an oligosaccharide
31. Phylogenetic perspectives in innate immunity
32. Interaction between the 35 kDa apolipoprotein of pulmonary surfactant and saturated phosphatidylcholines. Effects of temperature
33. Pulmonary surfactant protein A (SP-A) specifically binds dipalmitoylphosphatidylcholine
34. Binding of pulmonary surfactant protein A to galactosylceramide and asialo-GM2
35. The major glycolipid recognized by SP-D in surfactant is phosphatidylinositol
36. Pulmonary surfactant protein D specifically binds to phosphatidylinositol
37. Binding specificity of lung surfactant protein SP-D for glucosylceramide
38. Characterization of pulmonary surfactant protein D: Its copurification with lipids
39. Adsorption of pulmonary surfactant protein D to phospholipid monolayers at the air-water interface
40. Introduction of mannose binding protein-type phosphatidylinositol recognition into pulmonary surfactant protein A
41. The mannose-binding protein A region of glutamic acid185-alanine221 can functionally replace the surfactant protein A region of glutamic acid195-phenylalanine228 without loss of interaction with lipids and alveolar type II cells
42. Epitope mapping for monoclonal antibodies identifies functional domains of pulmonary surfactant protein A that interact with lipids
43. Importance of the carboxy-terminal 25 amino acid residues of lung collectins in interactions with lipids and alveolar type II cells
44. Site-directed mutagenesis of surfactant protein A reveals dissociation of lipid aggregation and lipid uptake by alveolar type II cells
45. Role of the C-terminal domain of pulmonary surfactant protein A in binding to alveolar type II cells and regulation of phospholipid secretion
46. Surfactant protein A amino acids Glu195 and Arg197 are essential for receptor binding, phospholipid aggregation, regulation of secretion, and the facilitated uptake of phospholipid by type II cells
47. Alveolar type II cells express a high-affinity receptor for pulmonary surfactant protein A
48. Lung surfactant apoprotein SP-A (26-36 kDa) binds with high affinity to isolated alveolar type II cells
49. Binding and uptake of surfactant protein D by freshly isolated rat alveolar type II cells
50. Specific binding of surfactant apoprotein SP-A to rat alveolar macrophages
51. Degradation of surfactant protein D by alveolar macro-GR62 phages
52. Surfactant protein D binding to alveolar macrophages
53. Membrane receptors for soluble defense collagens
54. Interaction of C1q receptor with lung suffactant protein A
55. cDNA cloning and primary structure analysis of C1qR(P), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro
56. Interaction of surfactant protein A with cellular myosin
57. Glycoprotein-340 binds surfactant protein-A (SP-A) and stimulates alveolar macrophage migration in an SP-A-independent manner
58. Ca(2+)-dependent binding of annexin IV to surfactant protein A and lamellar bodies in alveolar type II cells
59. Purification of a cell-surface receptor for surfactant protein A
60. Isolation and partial characterization of a receptor to surfactant protein A expressed by rat type II pneumocytes
61. Surfactant protein A-binding proteins. Characterization and structures
62. Identification of a new surfactant protein A binding protein at the cell membrane of rat type II pneumocytes
63. Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D
64. Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule
65. Microfibril-associated protein 4 is present in lung washings and binds to the collagen region of lung surfactant protein D
66. Molecular structure of pulmonary surfactant protein D (SP-D)
67. Chemistry and molecular genetics of C1q
68. Cutting edge: Complement-activating complex of ficolin and mannose-binding lectin-associated serine protease
69. Localization and developmental expression of surfactant proteins D and A in the respiratory tract of the mouse
70. Surfactant protein D: Subcellular localization in nonciliated bronchiolar epithelial cells
71. Immunocytochemical localization and identification of the major surfactant protein in adult rat lung
72. Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, clara cells, and alveolar macrophages of rat lung
73. Pulmonary surfactant protein A (SP-A) is expressed by epithelial cells of small and large intestine
74. Localization of lung surfactant protein D on mucosal surfaces in human tissues
75. Expression of pulmonary surfactant protein D in rat gastric mucosa
76. Surfactant protein A and D expression in the porcine Eustachian tube
77. Pulmonary surface tension and alveolar stability
78. Pulmonary surfactant metabolism
79. Functions of the alveolar lining
80. Surface active materials from dog lung. II. Composition and physiological correlations
81. Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28-36 in surfactant lipid adsorption
82. Low molecular weight human pulmonary surfactant protein (SP5): Isolation, characterization, and cDNA and amino acid sequences
83. Hydrophobic proteins of lamellated osmiophilic bodies isolated from pig lung
84. Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant. Characterization and biophysical activity
85. Surfactant protein composition of lamellar bodies isolated from rat lung
86. Lamellar bodies of cultured human fetal lung: Content of surfactant protein A (SP-A), surface film formation and structural transformation in vitro
87. Trafficking of newly synthesized surfactant protein A in isolated rat alveolar type II cells
88. Lung surfactant
89. Subfractionation of lung surfactant. Implications for metabolism and surface activity
90. Conversion of larnellar body membranes into tubular myelin in alveoli of fetal rat lungs
91. Isolation and characterization of lamellar bodies and tubular myelin from rat lung homogenates
92. Freeze-fracture study of alveolar lining layer in adult rat lungs
93. Protein composition of rabbit alveolar surfactant subfractions
94. Uptake of lung surfactant subfractions into lamellar bodies of adult rabbit lungs
95. Precursor-product relationship between rabbit type II cell lamellar bodies and alveolar surface-active material. Surfactant turnover time
96. Analysis of labeling and clearance of lung surfactant phospholipids in rabbit. Evidence of bidirectional surfactant flux between lamellar bodies and alveolar lavage
97. Localization of alveolar surfactant clearance in rabbit lung cells
98. Degradation of dipalmitoyl phosphatidylcholine by isolated rat granular pneumocytes and reutilization for surfactant synthesis
99. Reutilization of phosphatidylcholine analogues by the pulmonary surfactant system. The lack of specificity
100. Phagocytosis of surfactant by alveolar macrophages in vitro
101. Degradation of pulmonary surfactant disaturated phosphatidylcholines by alveolar macrophages
102. Surfactant phosphatidylcholine source, fluxes, and turnover times in 3-day-old, 10-day-old, and adult rabbits
103. Reutilization of surfactant phosphatidylcholine in adult rabbits
104. Surfactant homeostasis in the rat lung during swimming exercise
105. The pulmonary consequences of a deep breath
106. The release of surfactant in rat lung by brief periods of hyperventilation
107. Secretagogues for lung surfactant increase lung uptake of alveolar phospholipids
108. Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant
109. Changes in lipid structure produced by surfactant proteins SP-A, SP-B, and SP-C
110. Surfactant-associated protein inhibits phospholipid secretion from type II cells
111. Pulmonary surfactant and its components inhibit secretion of phosphatidylcholine from cultured rat alveolar type II cells
112. Surfactant-associated protein A is important for maintaining surfactant large-aggregate forms during surface-area cycling
113. Clearance and recycling of pulmonary surfactant
114. Ultrastructure of phospholipid mixtures reconstituted with surfactant proteins B and D
115. Lectin-mediated interactions of surfactant protein D with alveolar macrophages
116. Regulatory mechanisms of surfactant secretion
117. Pulmonary surfactant apoprotein A structure and modulation of surfactant secretion by rat alveolar type II cells
118. Surfactant protein D (SP-D) counteracts the inhibitory effect of surfactant protein A (SP-A) on phospholipid secretion by alveolar type II ceils. Interaction of native SP-D with SP-A
119. Chemical modification of surfactant protein A alters high affinity binding to rat alveolar type II cells and regulation of phospholipid secretion
120. Surfactant protein A is localized at the comers of the pulmonary tubular myelin lattice
121. Characteristics of surfactant from SP-A-deficient mice
122. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice
123. Morphological basis of alveolar-capillary gas exchange
124. Adsorption of natural lung surfactant and phospholipid extracts related to tubular myelin formation
125. Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoprotein
126. Role of bovine pulmonary surfactant-associated proteins in the surface-active property of phospholipid mixtures
127. Low-molecular mass surfactant protein type 1. The primary structure of a hydrophobic 8-kDa polypeptide with eight half-cystine residues
128. Hydrophobic surfactant-associated polypeptides; SP-C is a lipopeptide with two palmitoylated cisteine residues whereas SP-B lacks covalently linked fatty acyl groups
129. Brief report: Deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis
130. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro
131. Surfactant apoprotein A modifies the inhibitory effect of plasma proteins on surfactant activity in vivo
132. Alterations of acidic phospholipids in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis
133. Ultrastructural, histochemical, and freeze-fracture evaluation of multilamellated structures in human pulmonary alveolar proteinosis
134. Mechanical ventilation of rat lung: Effect on surfactant forms
135. Surfactant subtypes in mice: Characterization and quantitation
136. SP-A, SP-B, and SP-C in surfactant subtypes around birth: Reexamination of alveolar life cycle of surfactant
137. Surfactant subtypes of mice: Metabolic relationships and conversion in vitro
138. r =26,000-36,000 enhances uptake of liposomes by type II cells
139. Degradation of surfactant lipids and surfactant protein A by alveolar macrophages in vitro
140. The significance of reutilization of surfactant phosphatidylcholine
141. Surfactant protein A (SP-A) gene targeted mice
142. Surfactant metabolism in surfactant protein A-deficient mice
143. Surfactant protein-B supplementation improves in vivo function of a modified natural surfactant
144. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D
145. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo
146. Altered surfactant metabolism in the SP-D deficient mouse
147. Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation
148. Early alterations in intracellular and alveolar surfactant of the rat lung in response to endotoxin
149. Abnormally large lamellar bodies in type II pneumocytes in Chediak-Higashi syndrome in beige mice
150. Rescue of SP-B knockout mice with a truncated SP-B proprotein. Function of the C-terminal propeptide
151. GM-CSF enhances lung growth and causes alveolar type II epithehal cell hyperplasia in transgenic mice
152. Pulmonary malformation in transgenic mice expressing human keratinocyte growth factor in the lung
153. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice
154. Pulmonary-specific expression of SP-D corrects pulmonary lipid accumulation in SP-D gene-targeted mice
155. IL-4 increases surfactant and regulates metabolism in vivo
156. Altered regulation of surfactant phospholipid and protein A during acute pulmonary inflammation
157. Alterations of surfactant lipid turnover in silicosis: Evidence of a role for surfactant-associated protein A (SP-A)
158. Surfactant metabolic consequences of overexpression of GM-CSF in the epithelium of GM-CSFdeficient mice
159. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis
160. Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal
161. The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation